Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: Meta-analysis of individual patient data

Gut

Volumn 60, Issue 2, 2011, Pages 255-260

  Mathurin, Philippe ^a   O'Grady, John ^b   Carithers, Robert L ^c   Phillips, Martin ^b   Louvet, Alexandre ^a   Mendenhall, Charles L ^d   Ramond, Marie José ^e   Naveau, Sylvie ^f   Maddrey, Willis C ^g   Morgan, Timothy R ^h  

^a UNIV LILLE   (France)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c Department of Medicine ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BEAUJON HOSPITAL   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

^g UNIVERSITY OF TEXAS AT DALLAS   (United States)

^h VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CORTICOSTEROID; PLACEBO;

ALCOHOL LIVER DISEASE; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERIC FEEDING; HEPATIC ENCEPHALOPATHY; HUMAN; LEUKOCYTE COUNT; MEDICAL LITERATURE; PATIENT CODING; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOCORTICOIDS; HEPATIC ENCEPHALOPATHY; HEPATITIS, ALCOHOLIC; HUMANS; LIVER; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 78651071021     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.224097     Document Type: Article

References (32)

1. Lucey M, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360:2758-69.
2. Helman RA, Temko MH, Nye SW, et al. Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971;74:311-21.
3. Porter HP, Simon FR, Pope CE, et al. Corticosteroid therapy in severe alcoholic hepatitis. N Engl J Med 1971;284:1350-5.
4. Campra JL, Hamlin EM, Kirshbaum RJ, et al. Prednisone therapy of acute alcoholic hepatitis. Ann Intern Med 1973;79:625-31.
5. Blitzer BL, Mutchnick MG, Joshi PH, et al. Adrenocorticosteroid therapy in alcoholic hepatitis: a prospective, double-blind randomized study. Am J Dig Dis 1977;22:477-84.
6. Lesesne HR, Bozymski EM, Fallon HJ. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology 1978;74:169-73.
7. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9.
8. Shumaker JB, Resnick RH, Galambos JT, et al. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol 1978;69:443-9.
9. Theodossi A, Eddleston AL, Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982;23:75-9. (Pubitemid 12170180)
10. Depew W, Boyer T, Omata M, et al. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980;78:524-9. (Pubitemid 10183161)
11. Bories P, Guedj JY, Mirouze D, et al. Traitement de l'hépatite alcoolique aiguë par la prednisolone. Presse Med 1987;16:769-72.
12. Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984;311:1464-70.
13. Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-12.
14. Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Intern Med 1989;110:685-90.
15. Mathurin P, Mendenhall C, Carithers RL Jr, et al. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials. J Hepatol 2002;36:480-7.
16. Cabre E, Rodriguez-Iglesias P, Caballeria J, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000;32:36-42.
17. Phillips M, Curtis H, Portmann B, et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis: a randomised clinical trial. J Hepatol 2006;44:784-90.
18. Daures JP, Peray P, Bories P, et al. Place de la corticothérapie dans le traitement des hépatites alcooliques aiguës. Résultats d'une méta-analyse. Gastroenterol Clin Biol 1991;15:223-8.
19. Reynolds TB, Benhamou JP, Blake J, et al. Treatment of alcoholic hepatitis. Gastroenterol Int 1989;2:208-16.
20. Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis? Ann Intern Med 1990;113:299-307.
21. Christensen E, Gludd C. Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37:113-18.
22. Rambaldi A, Saconato HH, Christensen E, et al. Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008;27:1167-78.
23. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference. Lancet 1993;341:418-22.
24. Poynard T, Munteanu M, Ratziu V, et al. Truth survival in clinical research: an evidence based requiem? Ann Intern Med 2002;136:888-95.
25. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45:1348-54.
26. Louvet A, Wartel F, Castel H, et al. Prospective screening of infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009;137:541-8.
27. Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
28. Salerno F, Camma C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007;133:825-34. (Pubitemid 47374134)
29. Ahn J, Morgan TR, Cohen SM. Evaluation and managment of alcoholic hepatitis: a survey of current practices. Hepatology 2009;50:612A.
30. Mathurin P, Abdelnour M, Ramond MJ, et al. Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone. Hepatology 2003;38:1363-9. (Pubitemid 37466961)
31. Dureja P, Lucey MR. The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol 2010;52:759-64.
32. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology 2010;51:307-28.